FKIE_CVE-2022-26389
Vulnerability from fkie_nvd - Published: 2025-02-07 17:15 - Updated: 2025-02-07 17:15
Severity ?
Summary
An improper access control vulnerability may allow privilege escalation.This issue affects:
* ELI 380 Resting Electrocardiograph:
Versions 2.6.0 and prior;
* ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph:
Versions 2.3.1 and prior;
* ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior;
* ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph:
Versions 2.2.0 and prior.
References
Impacted products
| Vendor | Product | Version |
|---|
{
"cveTags": [],
"descriptions": [
{
"lang": "en",
"value": "An improper access control vulnerability may allow privilege escalation.This issue affects:\u00a0\n\n * ELI 380 Resting Electrocardiograph:\n\nVersions 2.6.0 and prior;\u00a0\n * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph:\n\nVersions 2.3.1 and prior;\u00a0\n * ELI 250c/BUR 250c Resting Electrocardiograph:\u00a0Versions 2.1.2 and prior;\u00a0\n * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: \n\nVersions 2.2.0 and prior."
},
{
"lang": "es",
"value": "Una vulnerabilidad de control de acceso inadecuado puede permitir la escalada de privilegios. Este problema afecta a: * Electrocardi\u00f3grafo en reposo ELI 380: versiones 2.6.0 y anteriores; * Electrocardi\u00f3grafo en reposo ELI 280/BUR280/MLBUR 280: versiones 2.3.1 y anteriores; * Electrocardi\u00f3grafo en reposo ELI 250c/BUR 250c: versiones 2.1.2 y anteriores; * Electrocardi\u00f3grafo en reposo ELI 150c/BUR 150c/MLBUR 150c: versiones 2.2.0 y anteriores."
}
],
"id": "CVE-2022-26389",
"lastModified": "2025-02-07T17:15:22.130",
"metrics": {
"cvssMetricV31": [
{
"cvssData": {
"attackComplexity": "HIGH",
"attackVector": "NETWORK",
"availabilityImpact": "HIGH",
"baseScore": 7.7,
"baseSeverity": "HIGH",
"confidentialityImpact": "LOW",
"integrityImpact": "LOW",
"privilegesRequired": "LOW",
"scope": "CHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H",
"version": "3.1"
},
"exploitabilityScore": 1.8,
"impactScore": 5.3,
"source": "productsecurity@baxter.com",
"type": "Secondary"
}
]
},
"published": "2025-02-07T17:15:22.130",
"references": [
{
"source": "productsecurity@baxter.com",
"url": "https://hillrom.com/en/responsible-disclosures/"
},
{
"source": "productsecurity@baxter.com",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-167-01"
}
],
"sourceIdentifier": "productsecurity@baxter.com",
"vulnStatus": "Awaiting Analysis",
"weaknesses": [
{
"description": [
{
"lang": "en",
"value": "CWE-284"
}
],
"source": "productsecurity@baxter.com",
"type": "Secondary"
}
]
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Loading…
Loading…